Purchases and Sales Made in Q4 2024 in Immunome Inc. (IMNM)
This table provides information about the institutional ownership of Immunome Inc. (IMNM) during Q4 2024. The information is specifically focused on institutions that hold shares of Immunome Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-251K- 17.12% |
$2.29M - $3.65M
|
1.22M
$10.4M
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-262K- 4.55% |
$2.39M - $3.81M
|
5.5M
$47.1M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-295K- 51.85% |
$2.69M - $4.28M
|
274K
$2.34M
|
|
|
Feb 13, 2025
Q4 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-406K- 93.84% |
$3.7M - $5.9M
|
26.7K
$228K
|